down arrow

Gland Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,401.40
8.15 (0.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,386.751,464.70

52 Week

1,200.002,220.95
Valuation
Technical
Day's Volume

CASH

6.11 lacs (0.17%) Volume

Shareholding (Dec 2024)

FII

5.04%

Held by 149 FIIs

DII

34.80%

Held by 47 DIIs

Promoter

51.83%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -5.11% of over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 23,089 Cr (Large Cap)

stock-summary
P/E

33.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.44%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

7.87%

stock-summary
Price to Book

2.61

Revenue and Profits (1 Year):
Net Sales:
1,384 Cr
(Quarterly Results - Dec 2024)
Net Profit:
205 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.44%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-17.51%
0%
-17.51%
1 Year
-21.85%
1.16%
-20.69%
2 Years
11.22%
1.44%
12.66%
3 Years
-57.09%
0.70%
-56.39%
4 Years
-44.61%
0.72%
-43.89%
5 Years
0%
0%
0.0%

Latest dividend: 20 per share ex-dividend date: Aug-16-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.58%
EBIT Growth (5y)
-5.11%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
34.32%
Dividend Payout Ratio
42.65%
Pledged Shares
0
Institutional Holding
39.84%
ROCE (avg)
25.07%
ROE (avg)
11.79%
Valuation key factors
Factor
Value
P/E Ratio
33
Industry P/E
33
Price to Book Value
2.61
EV to EBIT
22.60
EV to EBITDA
15.98
EV to Capital Employed
3.25
EV to Sales
3.57
PEG Ratio
32.59
Dividend Yield
1.44%
ROCE (Latest)
14.18%
ROE (Latest)
7.87%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 22 Schemes (32.37%)

FIIs

Held by 149 FIIs (5.04%)

Promoter with highest holding

Fosun Pharma Industrial Pte. Ltd (51.83%)

Highest Public shareholder

Mirae Asset Large & Midcap Fund (7.52%)

Individual Investors Holdings

3.3%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.55% vs 0.29% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 25.17% vs 13.75% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,384.05",
          "val2": "1,405.83",
          "chgp": "-1.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "359.96",
          "val2": "297.06",
          "chgp": "21.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "22.82",
          "val2": "6.11",
          "chgp": "273.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "204.69",
          "val2": "163.53",
          "chgp": "25.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.01%",
          "val2": "21.13%",
          "chgp": "4.88%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 8.73% vs 35.81% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -20.84% vs -17.48% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,807.54",
          "val2": "2,582.12",
          "chgp": "8.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "561.45",
          "val2": "618.04",
          "chgp": "-9.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "11.73",
          "val2": "10.96",
          "chgp": "7.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "307.29",
          "val2": "388.18",
          "chgp": "-20.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.00%",
          "val2": "23.94%",
          "chgp": "-3.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 1.56% vs 45.35% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -11.73% vs -17.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,191.59",
          "val2": "4,127.28",
          "chgp": "1.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "921.41",
          "val2": "974.43",
          "chgp": "-5.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "34.55",
          "val2": "16.24",
          "chgp": "112.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "511.98",
          "val2": "580.04",
          "chgp": "-11.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.98%",
          "val2": "23.61%",
          "chgp": "-1.63%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,664.72",
          "val2": "3,624.60",
          "chgp": "56.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,333.07",
          "val2": "1,024.77",
          "chgp": "30.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "26.20",
          "val2": "7.45",
          "chgp": "251.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-56.46",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "772.46",
          "val2": "781.04",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.53%",
          "val2": "28.27%",
          "chgp": "-4.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1,384.05
1,405.83
-1.55%
Operating Profit (PBDIT) excl Other Income
359.96
297.06
21.17%
Interest
22.82
6.11
273.49%
Exceptional Items
0.00
0.00
Consolidate Net Profit
204.69
163.53
25.17%
Operating Profit Margin (Excl OI)
26.01%
21.13%
4.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -1.55% vs 0.29% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 25.17% vs 13.75% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,807.54
2,582.12
8.73%
Operating Profit (PBDIT) excl Other Income
561.45
618.04
-9.16%
Interest
11.73
10.96
7.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
307.29
388.18
-20.84%
Operating Profit Margin (Excl OI)
20.00%
23.94%
-3.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 8.73% vs 35.81% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -20.84% vs -17.48% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,191.59
4,127.28
1.56%
Operating Profit (PBDIT) excl Other Income
921.41
974.43
-5.44%
Interest
34.55
16.24
112.75%
Exceptional Items
0.00
0.00
Consolidate Net Profit
511.98
580.04
-11.73%
Operating Profit Margin (Excl OI)
21.98%
23.61%
-1.63%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 1.56% vs 45.35% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -11.73% vs -17.42% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
5,664.72
3,624.60
56.29%
Operating Profit (PBDIT) excl Other Income
1,333.07
1,024.77
30.08%
Interest
26.20
7.45
251.68%
Exceptional Items
0.00
-56.46
100.00%
Consolidate Net Profit
772.46
781.04
-1.10%
Operating Profit Margin (Excl OI)
23.53%
28.27%
-4.74%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Gland Pharma Ltd stock-summary
stock-summary
Gland Pharma Ltd
Large Cap
Pharmaceuticals & Drugs
Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."